Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Circular Code Biology logo — Pioneering the Future of Medicine with Innovative Circular R...

Circular Code Biology

Pioneering the Future of Medicine with Innovative Circular RNA Therapies

Founded 2021 51-200 employees Series A Total: $20.00M Biopharma, Biotechnology +1

General Information

Company Name Circular Code Biology
Founded Year 2021
Employees 51-200
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series A
Social

BounceWatch is an independent company data service, not affiliated with Circular Code Biology. To contact Circular Code Biology, visit circodebio.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Circular Code Biology compare?

A PDF of Circular Code Biology and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Circular Code Biology soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Circular Code Biology

Circular Code Biology, a biomedical startup founded in 2021, is disrupting the future of medicine through its innovative circular RNA technology platform. With the slogan "Pioneering the Future of Medicine with Innovative Circular RNA Therapies," the company focuses on developing nucleic acid drugs. In its latest funding round in December 2021, Circular Code Biology secured a substantial $20.00M investment from Cowin Capital, Kaitai Capital, Kunlun Capital, and Yifeng Capital. Specializing in the biopharma, biotechnology, and pharmaceutical industries, the company shows promising potential in transforming the landscape of medicine and attracting notable investors.

Business keywords: biomedical, nucleic acid, circular RNA, therapy, drug development, pharmaceuticals, RNA technology, biotech, LNP, medicine

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A Undisclosed 1
Johnson & Johnson Innovation – JJDC
15 Aug 2023
Seed Round $20.00M 4
Cowin Capital Kaitai Capital Kunlun Capital
Cowin Capital, Kaitai Capital +2
16 Dec 2021

Circular Code Biology Alternatives & Competitors

View All Alternatives
Circular Code Biology vs
Yuanyin Bio
Yuanyin Bio

Pioneering the future of medicine with groundbreaking RNA technology to tackle unmet clinical needs...

Series A
Biopharma, Biotechnology
Circular Code Biology vs
Autotelic Bio Inc.
Autotelic Bio Inc. Korea South

RNA Therapeutics New Drug Development Company

Series B
15 employees
Biotechnology, Pharmaceutical
Circular Code Biology vs
Korro Bio, Inc.
Korro Bio, Inc. United States

Edit the message. Rewrite the future. Pioneering RNA editing to deliver the future of medicine.

IPO
75 employees
Biotechnology, Health Care
View all alternatives

FAQ About Circular Code Biology

Pioneering the Future of Medicine with Innovative Circular RNA Therapies
Circular Code Biology was founded in 2021.
Circular Code Biology operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on biomedical, nucleic acid, circular RNA and therapy.
Circular Code Biology has approximately 51-200 employees.
Circular Code Biology has completed 2 funding rounds, raising a total of $20.00M. The latest funding stage is Series A.
Top alternatives and competitors to Circular Code Biology include Yuanyin Bio, Autotelic Bio Inc., Korro Bio, Inc., Chuangjian Medical, LanteRNA. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Circular Code Biology and Yuanyin Bio are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Circular Code Biology, https://bouncewatch.com/company/circular-code-biology, updated 18 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes